187 related articles for article (PubMed ID: 27257787)
1. Cystathionine-beta-synthase inhibition for colon cancer: Enhancement of the efficacy of aminooxyacetic acid via the prodrug approach.
Chao C; Zatarain JR; Ding Y; Coletta C; Mrazek AA; Druzhyna N; Johnson P; Chen H; Hellmich JL; Asimakopoulou A; Yanagi K; Olah G; Szoleczky P; Törö G; Bohanon FJ; Cheema M; Lewis R; Eckelbarger D; Ahmad A; Módis K; Untereiner A; Szczesny B; Papapetropoulos A; Zhou J; Hellmich MR; Szabo C
Mol Med; 2016 Sep; 22():361-379. PubMed ID: 27257787
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Novel Aminooxyacetic Acid Prodrugs in Colon Cancer Models: Towards Clinical Translation of the Cystathionine β-Synthase Inhibition Concept.
Hellmich MR; Chao C; Módis K; Ding Y; Zatarain JR; Thanki K; Maskey M; Druzhyna N; Untereiner AA; Ahmad A; Xue Y; Chen H; Russell WK; Wang J; Zhou J; Szabo C
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439739
[TBL] [Abstract][Full Text] [Related]
3. Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer.
Druzhyna N; Szczesny B; Olah G; Módis K; Asimakopoulou A; Pavlidou A; Szoleczky P; Gerö D; Yanagi K; Törö G; López-García I; Myrianthopoulos V; Mikros E; Zatarain JR; Chao C; Papapetropoulos A; Hellmich MR; Szabo C
Pharmacol Res; 2016 Nov; 113(Pt A):18-37. PubMed ID: 27521834
[TBL] [Abstract][Full Text] [Related]
4. Aminooxyacetic acid (AOAA) sensitizes colon cancer cells to oxaliplatin via exaggerating apoptosis induced by ROS.
Yue T; Zuo S; Bu D; Zhu J; Chen S; Ma Y; Ma J; Guo S; Wen L; Zhang X; Hu J; Wang Y; Yao Z; Chen G; Wang X; Pan Y; Wang P; Liu Y
J Cancer; 2020; 11(7):1828-1838. PubMed ID: 32194794
[No Abstract] [Full Text] [Related]
5. Effect of S-adenosyl-L-methionine (SAM), an allosteric activator of cystathionine-β-synthase (CBS) on colorectal cancer cell proliferation and bioenergetics in vitro.
Módis K; Coletta C; Asimakopoulou A; Szczesny B; Chao C; Papapetropoulos A; Hellmich MR; Szabo C
Nitric Oxide; 2014 Sep; 41():146-56. PubMed ID: 24667534
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer.
Szabo C; Coletta C; Chao C; Módis K; Szczesny B; Papapetropoulos A; Hellmich MR
Proc Natl Acad Sci U S A; 2013 Jul; 110(30):12474-9. PubMed ID: 23836652
[TBL] [Abstract][Full Text] [Related]
7. H
Petrosino M; Zuhra K; Kopec J; Hutchin A; Szabo C; Majtan T
Cell Mol Life Sci; 2022 Jul; 79(8):438. PubMed ID: 35864237
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance induces the upregulation of H
Untereiner AA; Pavlidou A; Druzhyna N; Papapetropoulos A; Hellmich MR; Szabo C
Biochem Pharmacol; 2018 Mar; 149():174-185. PubMed ID: 29061341
[TBL] [Abstract][Full Text] [Related]
9. Both the H
Ahmad A; Szabo C
Pharmacol Res; 2016 Nov; 113(Pt A):348-355. PubMed ID: 27639598
[TBL] [Abstract][Full Text] [Related]
10. H
Untereiner AA; Oláh G; Módis K; Hellmich MR; Szabo C
Biochem Pharmacol; 2017 Jul; 136():86-98. PubMed ID: 28404377
[TBL] [Abstract][Full Text] [Related]
11. Endogenous H
Wang W; Bo Q; Du J; Yu X; Zhu K; Cui J; Zhao H; Wang Y; Shi B; Zhu Y
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1077-F1086. PubMed ID: 29357418
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic potential of cystathionine β-synthetase/hydrogen sulfide inhibition in cancer.
Hellmich MR; Coletta C; Chao C; Szabo C
Antioxid Redox Signal; 2015 Feb; 22(5):424-48. PubMed ID: 24730679
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of Cystathionine-β-Synthase in Colonic Epithelia Reprograms Metabolism and Promotes Carcinogenesis.
Phillips CM; Zatarain JR; Nicholls ME; Porter C; Widen SG; Thanki K; Johnson P; Jawad MU; Moyer MP; Randall JW; Hellmich JL; Maskey M; Qiu S; Wood TG; Druzhyna N; Szczesny B; Módis K; Szabo C; Chao C; Hellmich MR
Cancer Res; 2017 Nov; 77(21):5741-5754. PubMed ID: 28923859
[TBL] [Abstract][Full Text] [Related]
14. Role of the cystathionine β-synthase/H2S system in liver cancer cells and the inhibitory effect of quinolone-indolone conjugate QIC2 on the system.
Jia H; Ye J; You J; Shi X; Kang W; Wang T
Oncol Rep; 2017 May; 37(5):3001-3009. PubMed ID: 28440458
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen sulfide upregulates renal AQP-2 protein expression and promotes urine concentration.
Luo R; Hu S; Liu Q; Han M; Wang F; Qiu M; Li S; Li X; Yang T; Fu X; Wang W; Li C
FASEB J; 2019 Jan; 33(1):469-483. PubMed ID: 30036087
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen sulfide-induced enhancement of gastric fundus smooth muscle tone is mediated by voltage-dependent potassium and calcium channels in mice.
Meng XM; Huang X; Zhang CM; Liu DH; Lu HL; Kim YC; Xu WX
World J Gastroenterol; 2015 Apr; 21(16):4840-51. PubMed ID: 25944997
[TBL] [Abstract][Full Text] [Related]
17. Role of cystathionine β-synthase in human breast Cancer.
Sen S; Kawahara B; Gupta D; Tsai R; Khachatryan M; Roy-Chowdhuri S; Bose S; Yoon A; Faull K; Farias-Eisner R; Chaudhuri G
Free Radic Biol Med; 2015 Sep; 86():228-38. PubMed ID: 26051168
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological actions of the slow release hydrogen sulfide donor GYY4137 on phenylephrine-induced tone in isolated bovine ciliary artery.
Chitnis MK; Njie-Mbye YF; Opere CA; Wood ME; Whiteman M; Ohia SE
Exp Eye Res; 2013 Nov; 116():350-4. PubMed ID: 24145109
[TBL] [Abstract][Full Text] [Related]
19. Potential role of the gaseous mediator hydrogen sulphide (H2S) in inhibition of human colonic contractility.
Martinez-Cutillas M; Gil V; Mañé N; Clavé P; Gallego D; Martin MT; Jimenez M
Pharmacol Res; 2015 Mar; 93():52-63. PubMed ID: 25641403
[TBL] [Abstract][Full Text] [Related]
20. Endogenous hydrogen sulfide inhibition suppresses tumor growth by promoting apoptosis and pyroptosis in esophageal cancer cells.
Wang HG; Wang D; Sarfraz M; Afzal A; Jing MR; Zhang YX; Cai CB; Qi HW; Chen HJ; Li T; Hu SJ; Liu HX; Ji XY; Wu DD
Transl Oncol; 2023 Dec; 38():101770. PubMed ID: 37716259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
